🇺🇸 FDA

Company profile · Sponsor

Spero

Spero Therapeutics

SPRO · NYSE pharma CAMBRIDGE, MA, USA
Pipeline
21
Drugs
0
Patents
8

Quick answer

Spero (SPRO) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker SPRO
Exchange NYSE
Company type pharma
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0001701108

Pipeline (21)

Search pipeline →

  1. TBP-PI-HBr

    Spero

    Urinary Tract Infection

    phase 3 small molecule completed

    1 trial

  2. TBPM-PI-HBr

    Spero

    Complicated Urinary Tract Infection

    phase 3 small molecule completed

    1 trial

  3. Tebipenem pivoxil, SODIUM CHLORIDE, IMIPENEM AND CILASTATIN , Placebo to match Tebipenem pivoxil, tablet

    Spero

    complicated urinary tract infection (cUTI) or acute pyelonephritis (AP)

    phase 3 small molecule active

    1 trial

  4. Placebo

    Spero

    Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

    phase 2 small molecule completed

    1 trial

  5. SPR720

    Spero

    Mycobacterium Avium Complex

    phase 2 small molecule terminated

    1 trial

  6. SPR206

    Spero

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  7. SPR206

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. SPR720

    Spero

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  9. SPR720

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. SPR720 for SAD

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. SPR741

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  12. SPR994

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. TBP-PI-HBr

    Spero

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  14. TBP-PI-HBr

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. TBPM-PI-HBr

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  16. Tebipenem Pivoxil Hydrobromide

    Spero

    Diabetes

    phase 1 small molecule completed

    1 trial

  17. Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo

    Spero

    TQT Study

    phase 1 small molecule completed

    1 trial

  18. Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)

    Spero

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  20. Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Reference

    Spero

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. Tebipenem tablet form

    Spero

    Relative Bioavailability

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12428395

    Heterocyclic compounds as kinase inhibitor and uses thereof

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12291548

    Compounds, compositions, and methods for the treatment of disease

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12226403

    Tebipenem pivoxil immediate and modified release oral dosage forms

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12146004

    Polymyxin compounds and uses thereof

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12048691

    High dosage tebipenem pivoxil tablet formulation

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11718621

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11459357

    Polymyxin compounds

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Spero?

Spero (SPRO) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Spero sponsor?

We track 21 ClinicalTrials.gov-linked programs for Spero, including TBP-PI-HBr and 20 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Spero company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.